Skip to main content
. 2022 Feb 1;25(1):35–42. doi: 10.4103/aian.aian_888_21

Table 5.

Choice of ASMs based on comorbidities and side benefits of medicines

Comorbidity Preferred ASM Drug (s) to be avoided
Obesity Topiramate Valproate
Zonisamide
Depression Lamotrigine Levetiracetam
Valproate
Cognitive dysfunction Lamotrigine Topiramate
Levetiracetam Zonisamide
Valproate
Migraine Valproate NA
Topiramate
Lamotrigine
Neuropathic pain Lamotrigine NA

ASM: Antiseizure medicine